Editorial
In memoriam: Professor Adi F. Gazdar, a pre-eminent pathologist and devoted man
Translational Lung Cancer Research
2019;
8
(3)
:200-201
.
(30 June 2019)
Immunotherapy for non-small cell lung cancer: from clinical trials to real-world practice
Translational Lung Cancer Research
2019;
8
(3)
:202-207
.
(30 June 2019)
Original Article
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of benign pulmonary lesions in sarcoidosis
Translational Lung Cancer Research
2019;
8
(3)
:208-213
.
(30 June 2019)
Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis
Translational Lung Cancer Research
2019;
8
(3)
:214-226
.
(30 June 2019)
Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(3)
:227-234
.
(30 June 2019)
Whole genome sequencing revealed microbiome in lung adenocarcinomas presented as ground-glass nodules
Translational Lung Cancer Research
2019;
8
(3)
:235-246
.
(30 June 2019)
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(3)
:247-257
.
(30 June 2019)
Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: a single institution, retrospective cohort study
Translational Lung Cancer Research
2019;
8
(3)
:258-267
.
(30 June 2019)
EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases
Translational Lung Cancer Research
2019;
8
(3)
:268-279
.
(30 June 2019)
Study Protocol
A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial
Translational Lung Cancer Research
2019;
8
(3)
:280-285
.
(30 June 2019)
Review Article
Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey
Translational Lung Cancer Research
2019;
8
(3)
:286-301
.
(30 June 2019)
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
Translational Lung Cancer Research
2019;
8
(3)
:302-316
.
(30 June 2019)
News
The First Impact Factor for Translational Lung Cancer Research: 4.806
Translational Lung Cancer Research
2019;
8
(3)
:E1
.
(30 June 2019)
